Cancer Therapeutics, Inc., an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire a minority ownership share of NanoTherapies, LLC. in an equity transaction.
Voxtel has announced the release of its Siletz series of APD receivers, responding to the demand for eye-safe and highly sensitive optical communications, LIDAR, and LADAR in the near infrared spectrum.
Australian nanotechnology firm NanoVentures Australia Ltd through its operating company NanoVic Commercial Pty Ltd has reached agreement with Italian pharmaceutical company SARM Allergeni Srl. to co-develop technology for the transdermal delivery of the anti-allergy reagent Sarmexall.
Under the long-term agreement, the companies will work together to utilize Nano Terra's surface engineering technology to develop the fabrication of thin films for certain military and commercial aerospace applications designed specifically to enhance performance.
Thermo Fisher Scientific will showcase industry-leading technologies that deliver improved performance and productivity for research, manufacturing and process applications at ACHEMA 2009, being held in Frankfurt, Germany, from May 11 - 15.
Starpharma Holdings Limited today announced the signing of a collaborative research, license and commercialisation agreement with Elanco, the animal health division of US pharmaceutical company Eli Lilly and Company.
Nanocomp Technologies, Inc., a developer of energy saving performance materials and component products from carbon nanotubes, today announced that it has been awarded a research contact to further develop nanotechnology-based products for use in aerospace applications.
Rudolph Technologies, Inc. announced today the availability of its new MetaPULSE-G thin film measurement tool optimized specifically for copper damascene processes at 45nm through 22nm technology nodes and copper via fill in new 3D IC applications.
NanoLogix, Inc. has announced the creation of its Science Advisory Board to help evaluate and target research and development efforts for products. The new advisory board provides the company with a vastly expanded scope of expertise in both medicine and biomedical research.
ExxonMobil Chemical announces the development of two new grades of V series co-extruded battery separator films. These new developmental grades will help make lithium-ion batteries safer than ever before for hybrid and electric vehicles, power tools and electronic devices including laptop computers.